[HTML] from ascopubs.orgAK Burnett, RK Hills, D Milligan… - Journal of Clinical …, 2011 - jco.ascopubs.org ... Identification of Patients With AcuteMyeloblasticLeukemia Who Benefit From the Addition of Gemtuzumab Ozogamicin: Results of the MRC AML15 Trial. ... Vellenga E,; Griffin JD. (1987) The biology of acutemyeloblasticleukemia. Semin Oncol 14:365–371. ... Cited by 18 - Related articles - All 5 versions
M Jan, MP Chao, AC Cha… - Proceedings of the …, 2011 - National Acad Sciences ... Prospective separation of normal and leukemic stem cells based on differential expression of TIM3, a human acute myeloid leukemia stem cell marker. ... PCT/US2009/000224 entitled “Markers of Acute Myeloid Leukemia Stem Cells.”. This article is a PNAS Direct Submission. ... Related articles - All 3 versions
[PDF] from stemcellres.comEJ Gudgin… - Stem Cell Research & Therapy, 2011 - Springer Page 1. Acute myeloid leukemia (AML) is an aggressive hemato- logical malignancy characterized by a proliferation of primitive myeloid cells or 'blasts' in the blood. ... 2010 BioMed Central Ltd Acute myeloid leukemia: leukemia stem cells write a prognostic signature ... Related articles - All 4 versions
[HTML] from 171.66.121.246VI Gaidzik, L Bullinger, RF Schlenk… - Journal of Clinical …, 2011 - 171.66.121.246 ... RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group. ... Abstract. Purpose To evaluate frequency, biologic features, and clinical relevance of RUNX1 mutations in acute myeloid leukemia (AML). ... Cited by 3 - Related articles - All 6 versions
[HTML] from jcojournal.orgY Chen, J Cortes, Z Estrov, S Faderl… - Journal of Clinical …, 2011 - jcojournal.org ... INTRODUCTION. Acute myeloid leukemia (AML) is a heterogeneous group of clonal hematopoietic progenitor cell disorders. ... (1992) Cytogeneticcs for detection of minimal residual disease in acutemyeloblasticleukemia. Leukemia 6:500–506. ... Related articles - All 5 versions